BC
ASMB icon

Boxer Capital’s Assembly Biosciences ASMB Stock Holding History

Boxer Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-125,000
Closed -$5.22M – 73
2021
Q3 		$5.22M Hold
125,000
– – 0.18% 69
2021
Q2 		$5.82M Hold
125,000
– – 0.21% 74
2021
Q1 		$6.9M Hold
125,000
– – 0.23% 65
2020
Q4 		$9.07M Buy
+125,000
New +$14.7M 0.29% 58

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Boxer Capital's ASMB Position: Q4 2021 in Review

Boxer Capital sold out of Assembly Biosciences (ASMB) in Q4 2021, closing a stake of 125,000 shares — an estimated $5.22M sold.

Boxer Capital first reported a position in ASMB in Q4 2020 and held it in 4 quarters. The position peaked at $9.07M in Q4 2020. 62 funds tracked by Wall St. Rank hold ASMB as of Q4 2021.

  • Boxer Capital reported no remaining Assembly Biosciences position as of Q4 2021 after selling out during the quarter.
  • Boxer Capital sold 125,000 Assembly Biosciences shares in Q4 2021, an estimated $5.22M.
  • Boxer Capital first reported a position in Assembly Biosciences in Q4 2020 and held it in 4 quarters.
  • Boxer Capital's Assembly Biosciences position peaked at $9.07M in Q4 2020.
  • 62 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2021.

Based on Boxer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.